Raymond James Financial Services Advisors, Inc. Gilead Sciences, Inc. Put Options Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

Put Options

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $1.82 Million - $2.29 Million	31,500 Added 139.38%	54,100 $165,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $823,976 - $935,228	-12,700 Reduced 35.98%	22,600 $2,000
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $135,380 - $146,060	2,000 Added 6.01%	35,300 $79,000
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $1.33 Million - $1.46 Million	21,000 Added 170.73%	33,300 $92,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $156,530 - $183,744	2,200 Added 21.78%	12,300 $77,000
Q2 2017 Aug 15, 2017	BUY	N/A	10,100	10,100 $97,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.5 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.99 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.65 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.5 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account